Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel

The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.

from NYT > Top Stories https://ift.tt/3o9frsb Read about Implantation bleeding quiz https://urlzs.com/fZw6K Chlamydia in men https://urlzs.com/W3NV1 https://ift.tt/2KrY6cn https://youtu.be/QFwQ6JvyPa8